Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | PCX12 |
Synonyms | |
Therapy Description |
PCX12 is encapsulated IL-12, which potentially increases antitumor immune activity (Cancer Res (2022) 82 (12_Supplement): 2086). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
PCX12 | PCX-12|PCX 12 | PCX12 is encapsulated IL-12, which potentially increases antitumor immune activity (Cancer Res (2022) 82 (12_Supplement): 2086). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06217666 | Phase I | PCX12 | Study Examining the Safety and Toxicity of Stereotactic Body Radiotherapy (SBRT) Followed by PCX12 Immunotherapy Delivered by Intratumoral Injection for the Treatment of Patients With Locally Advanced Pancreatic Adenocarcinoma (LAPC) | Not yet recruiting | USA | 0 |